In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Mendor brings in €8.1mm through its Series B round

Executive Summary

Mendor Oy (diabetes care products) has raised €8.1mm ($11.64mm) through its Series B venture round. Finnish entrepreneur Risto Siilasmaa led and was joined by Life Sciences Partners, Finnish Industry Investment, Ilmarinen (a Finnish mutual pension insurance company), Biothom, and returning shareholder Finnvera. LSP will contribute one board member.
Deal Industry
  • In Vitro Diagnostics
    • Glucose Testing
  • Medical Devices
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies